Study Comparing the Handling of Two Peripheral IV Catheter Systems

January 21, 2019 updated by: B. Braun Melsungen AG

Clinical Investigation Acc. to MPG §23b: Open-label Prospective Study Comparing the Handling of the Handling of Two Peripheral IV Catheter (PIV) Systems (Ported and Non Ported) in Randomized Order

A peripheral intravenous catheter is the most commonly used vascular access device in medicine. Primary objective is to compare insertion and handling of two peripheral intravenous catheters in clinical routine.

Study Overview

Study Type

Observational

Enrollment (Actual)

2340

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Berlin, Germany, 13353
        • Klinik für Anästhesiologie mit Schwerpunkt operative Intensivmedizin CVK/CCM, Charité-Universitätsmedizin Berlin
      • Tübingen, Germany
        • Universitätsklinik für Anästhesiologie und Intensivmedizin Tübingen

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Adults and children

Description

Inclusion:

  • Patients of the center Anesthesiology, Operating-Room Management and Intensive Care Medicine, Gynaecology and Paediatrics in need for peripheral intravenous access
  • Male and female patients, adult and paediatric
  • Is able to give written informed consent, for children the legal representatives

Exclusion:

  • Participation in another intervention trial during the study
  • Lacking willingness to save and hand out data within the study
  • Accommodation in an institution due to an official or judicial order
  • The potential insertion site shows deformities, phlebitis, infiltration, dermatitis, burns, lesions, nerve injuries with paresthesia or tattoos
  • Study PIV catheter site will be placed below an old infusion site
  • Patient has a documented or known allergy sensitivity to a medical adhesive product such as transparent film, adhesive dressing, tapes or liquid skin protectants
  • Patient requires the application of a topical ointment, or solution under the dressing in addition to the prep required in the protocol
  • Patient has or had previous IV catheter-related phlebitis or infiltration during this hospitalization
  • Patients with fear of injection
  • Preterm infants

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Vasofix® Safety
Peripheral IV catheter Vasofix® Safety
Intravenous access according to Instructions For Use
Introcan Safety®
Peripheral IV catheter Introcan Safety® IV catheter
Intravenous access according to Instructions For Use

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Incidence of successful puncturing on the first attempt
Time Frame: From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours
From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of insertion failures
Time Frame: From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours
From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours
Rate of difficulties to insert catheter and to withdraw the needle with regard to:Penetration characteristics of the needle, insertion and movement of catheter
Time Frame: From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours
From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours
Rate and number of testing of ease of moving
Time Frame: From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours
From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours
Rate and number of recannulation
Time Frame: From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours
From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours
Rate, number and kind/extend of blood emission
Time Frame: From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours
From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours
Incidence of needle stick injuries
Time Frame: During catheter fixation
During catheter fixation
Condition of fixation after completion of catheter insertion
Time Frame: During catheter fixation until directly after catheter insertion
dry and clean, moisturized, soiled?
During catheter fixation until directly after catheter insertion
Rate of adherence to standard application requirements of catheter placement
Time Frame: During catheter fixation until directly after catheter fixation
During catheter fixation until directly after catheter fixation
For Vasofix Safety: Rate and nature of use of application port
Time Frame: From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours
From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours
General judgment of catheter (school class grading)
Time Frame: From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours
From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours
Adverse Events
Time Frame: From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours
From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Age and gender of the patient
Time Frame: At the beginning of the investigation
At the beginning of the investigation
ASA score of the patient
Time Frame: At the beginning of the investigation
At the beginning of the investigation
Weight and height of the patient
Time Frame: At the beginning of the investigation
At the beginning of the investigation
Vein and skin condition of the patient
Time Frame: At the beginning of the investigation
At the beginning of the investigation
Location of Peripheral Intervenous Catheter
Time Frame: After catheter fixation
After catheter fixation
Judgment on application port and wings given by user
Time Frame: From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours
From catheter fixation until the stay in operation theatre and/or recovery room up to 12 hours
Working experience of the user
Time Frame: At the beginning of the investigation
Working experience of the user in a hospital in at the beginning of the investigation
At the beginning of the investigation
Function of the user
Time Frame: At the beginning of the investigation
Job title of the user
At the beginning of the investigation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Claudia Spies, Univ.- Prof. Dr., Klinik für Anästhesiologie mit Schwerpunkt operative Intensivmedizin CVK/CCM, Charité-Universitätsmedizin Berlin

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2014

Primary Completion (Actual)

March 1, 2016

Study Completion (Actual)

March 1, 2016

Study Registration Dates

First Submitted

July 22, 2014

First Submitted That Met QC Criteria

August 8, 2014

First Posted (Estimate)

August 12, 2014

Study Record Updates

Last Update Posted (Actual)

January 23, 2019

Last Update Submitted That Met QC Criteria

January 21, 2019

Last Verified

January 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • HC-O-H 1411

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intravenous Access According to Instructions For Use

Clinical Trials on Peripheral IV catheter

3
Subscribe